Upadacitinib Reveals Optimistic Endoscopic Outcomes in Crohn’s Illness
Dr Brian Feagan COPENHAGEN, Denmark — The reversible oral Janus kinase (JAK) inhibitor upadacitinib (Rinvoq, AbbVie) was related to superior...
Endoscopic
Dr Brian Feagan COPENHAGEN, Denmark — The reversible oral Janus kinase (JAK) inhibitor upadacitinib (Rinvoq, AbbVie) was related to superior...
